Castot A - Search Results

1

Place des études post-AMM dans le suivi des risques du médicament : cahier des charges et méthodologies.

Tubach F, Lamarque-Garnier V, Castot A; participants à la Table Ronde N◦ 5 de Giens XXVI. Tubach F, et al. Among authors: castot a. Therapie. 2011 Jul-Aug;66(4):347-54. doi: 10.2515/therapie/2011041. Therapie. 2011. PMID: 27392461 French. No abstract available.

2

Role of the post-marketing authorisation studies in drug risk surveillance: specifications and methodologies.

Tubach F, Lamarque-Garnier V, Castot A; participants of Round Table N° 5 of Giens XXVI. Tubach F, et al. Among authors: castot a. Therapie. 2011 Jul-Aug;66(4):355-62, 347-54. doi: 10.2515/therapie/2011048. Epub 2011 Aug 19. Therapie. 2011. PMID: 21851800 Free article. English, French.

3

[Adverse drug reactions: a pilot study on patient reporting through patient associations].

Nasrallah-Irles D, Castot A, Thomas L, Babai S, Delorme B, Le-Louët H. Nasrallah-Irles D, et al. Among authors: castot a. Therapie. 2008 Sep-Oct;63(5):385-92. doi: 10.2515/therapie:2008060. Epub 2009 Jan 21. Therapie. 2008. PMID: 19154708 French.

4

[Periodic report of pharmacovigilance: new recommendations, results of a survey among 200 pharmaceutical laboratories].

Castot A, Lerebours S, de Roef P, Alexandre JM. Castot A, et al. Therapie. 1996 Sep-Oct;51(5):554-5. Therapie. 1996. PMID: 9138392 French. No abstract available.

5

[Evaluation of declarations of severe adverse effects from the publication of the decree dated 13 March 1995 about the organisation of pharmacovigilance].

Lelouet H, Morin M, Trenque T, Bidault I, Castot A, Alexandre JM. Lelouet H, et al. Among authors: castot a. Therapie. 1996 Sep-Oct;51(5):555-6. Therapie. 1996. PMID: 9138393 French. No abstract available.

6

[Antidepressants and cardiac side effects. Evaluation trial].

Efthymiou ML, Castot A. Efthymiou ML, et al. Among authors: castot a. Therapie. 1992 Sep-Oct;47(5):375-81. Therapie. 1992. PMID: 1299975 Review. French.

7

[Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].

Castot A, Djezzar S, Deleau N, Guillot B, Efthymiou ML. Castot A, et al. Therapie. 1997 Mar-Apr;52(2):97-103. Therapie. 1997. PMID: 9231502 Review. French.

8

[Evaluation of unexpected and toxic effects of omeprazole (Mopral) reported to the regional centers of pharmacovigilance during the first 22 postmarketing months].

Castot A, Bidault I, Dahan R, Efthymiou ML. Castot A, et al. Therapie. 1993 Sep-Oct;48(5):469-74. Therapie. 1993. PMID: 8146827 French.

9

[Acute methotrexate poisoning: apropos of 16 cases reported to the Paris Poison Control Center and review of the literature].

Maignen F, Guillot B, Pierron E, Julian S, Castot A. Maignen F, et al. Among authors: castot a. Therapie. 1996 Sep-Oct;51(5):527-31. Therapie. 1996. PMID: 9138387 Review. French.

10

[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].

Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance. Durrieu G, et al. Among authors: castot a. Therapie. 2011 Nov-Dec;66(6):527-40. doi: 10.2515/therapie/2011075. Epub 2011 Dec 21. Therapie. 2011. PMID: 22186078 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters